Related by context. Frequent words. (Click for all words.) 73 Drug Candidate 73 Phase III Clinical Trial 71 Phase III Trial 71 Completes Enrollment 70 Clinical Trial Results 69 Preclinical Data 69 FDA Accepts 69 II Clinical Trial 68 Well Tolerated 68 Patients Treated 68 Presents Positive 68 Pivotal Phase 68 Chronic Hepatitis C 67 Pivotal Phase III 67 Patient Enrollment 67 Study Demonstrates 67 FDA Clears 67 Initiate Phase 66 Monotherapy 66 Initiates Phase 66 Recombinant Human 66 Pivotal Trial 65 Receives FDA Clearance 65 Benign Prostatic Hyperplasia 65 Tolerability 65 Generic Version 65 Positive Opinion 64 Significantly Reduces 64 Capecitabine 64 Monoclonal Antibody 64 Combination Therapy 63 Low Dose 63 Shows Promise 63 Irinotecan 63 Clinical Study 63 Elderly Patients 63 Inhibits 63 FDA Approves 62 Patients Undergoing 62 Pulmonary Arterial Hypertension 62 Overactive Bladder 62 Metastatic Colorectal Cancer 62 Announces Positive 62 Reports Positive 62 liposomal formulation 62 Develop Novel 62 Reduces Risk 62 Heart Failure Patients 62 Extended Release 61 Announces Publication 61 Induces 61 Diabetic Patients 61 Allergic Rhinitis 61 Drug Resistant 61 Chronic Heart Failure 61 Increases Risk 61 Metastatic Melanoma 60 Phase IIa trial 60 Atopic Dermatitis 60 Postmenopausal Women 60 Post Operative 60 Antipsychotic 60 Patent Covering 60 Commercialize 59 Newly Diagnosed 59 Prostate Cancer Patients 59 Acute Myocardial Infarction 59 Gastric Cancer 59 Announces Presentation 59 RNAi Therapeutics 59 Immunogenicity 59 Small Molecule 59 Achieves Milestone 59 Cardiovascular Events 59 administered subcutaneously 59 Factor VIIa 59 FDA Clearance 59 Inhibitor 59 Ischemic 59 Acute Coronary Syndromes 58 Meta Analysis 58 Cholesterol Drug 58 Insulin Resistance 58 Holds Promise 58 Advanced Prostate Cancer 58 Venous Thromboembolism 58 FDA Approval 58 Tesetaxel 58 Drug Eluting Stents 58 Receives Patent 58 Solid Tumors 58 Significantly Increases 58 KRN# 58 k Clearance 58 Blood Thinner 58 Phase 2a clinical 57 Drug Eluting Stent 57 Phase IIIb 57 Ofatumumab 57 Carotid 57 Patent Issued